Among these, prevalence of grade 3-4 cytopenia, including neutropenia, anemia, and thrombocytopenia, was 26%, 6%, 24% respectively, with no difference between the early G-CSF group and the control group (Table 3 and Fig. 3a). The gene discussed is CSF3; the disease is anemia (phenotype).